Stay updated on Vobramitamab Dose Levels in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.4.3, replacing the previous entry Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:19:18.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Adds entries for Business reasons and Terminated, and records that Results were posted, including Outcome Measures and Results, along with a new revision (v3.4.2) and updated dates (2026-02-09 and 2026-01-21).
    Difference
    1%
    Check dated 2026-02-11T02:38:05.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated the revision tag to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-03T23:44:35.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The Record History page adds a glossary toggle and color-coded change indicators (green for additions, red for deletions). The revision label updated from v3.3.4 to v3.4.0 and the No FEAR Act Data line was removed.
    Difference
    0.8%
    Check dated 2026-01-28T00:17:45.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Record history now includes a new revision entry v3.3.4, and the previous revision v3.3.3 is removed from the list.
    Difference
    0.1%
    Check dated 2026-01-13T17:48:38.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Version history shows a new entry Returned: 2025-12-16 and an update to Revision: v3.3.3, with new core sections added (Outcome Measures, Outcome Measures (Results), and Study Status). The item HHS Vulnerability Disclosure and the previous Revision: v3.3.2 were removed.
    Difference
    0.7%
    Check dated 2025-12-23T07:33:28.000Z thumbnail image

Stay in the know with updates to Vobramitamab Dose Levels in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page.